Results 11 to 20 of about 14,074 (215)

Thyroid-stimulating immunoglobulin levels during low-dose antithyroid therapy predict Graves’ disease relapse [PDF]

open access: yesFrontiers in Endocrinology
BackgroundGraves’ disease (GD) is a common autoimmune disorder often treated with antithyroid drugs (ATD), but relapse rates remain high after therapy withdrawal.
Phong Vu Nhat Nguyen, Khue Thy Nguyen
doaj   +2 more sources

Thyroid-stimulating immunoglobulins in neonatal Graves's disease. [PDF]

open access: bronzeArchives of Disease in Childhood, 1980
Two patients with neonatal Graves's disease are reported. One of them had a delayed onset because of suppression of the fetal thyroid gland by antithyroid drug taken by the mother during pregnancy. Thyroid-stimulating immunoglobulins (TSAb), measured by a receptor assay, were present in both babies when they were thyrotoxic, and also in their mothers ...
C.S. Teng   +3 more
openalex   +4 more sources

Evaluating the patient's serum for thyroid stimulating immunoglobulin and Cytotoxic -T-lymphocyte associated protein 4 in Graves hyperthyroidism

open access: diamondمجلة علوم ذي قار
Graves' disease (GD) is a common autoimmune disorder that causes an excess of thyroid hormone production. It is mainly due to the production of IgG antibodies that activate the thyrotropin receptor.
Alkhansaa Tariq   +2 more
doaj   +2 more sources

A study of thyroid-stimulating immunoglobulins in thyroid diseases

open access: gold, 1980
published_or_final_version ; Medicine ; Master ; Doctor of ...
Chong-shing Teng
openalex   +3 more sources

Home - About - Disclaimer - Privacy